Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly KIT exon 8 mutation. (A molecular genetic abnormality indicating the presence of a mutation in exon 8 of the KIT gene located within 4q11-q12.)
No clinical trials have been registered for acute myeloid leukemia, KIT exon 8 mutation.
5 publications have been identified in PubMed for acute myeloid leukemia, KIT exon 8 mutation. Research spans Case Report / Case Series (40%), Review / Meta-Analysis (20%), and Clinical Trial Publication (20%).
Ji Q (2026). [PMID: 41697365](https://pubmed.ncbi.nlm.nih.gov/41697365/). *Annals of hematology*. [Clinical Trial Publication]
Apperley JF (2025). [PMID: 40646132](https://pubmed.ncbi.nlm.nih.gov/40646132/). *Leukemia*. [Review / Meta-Analysis]
Chen X (2025). [PMID: 40586868](https://pubmed.ncbi.nlm.nih.gov/40586868/). *Annals of hematology*. [Case Report / Case Series]
Smith MA (2024). [PMID: 39510293](https://pubmed.ncbi.nlm.nih.gov/39510293/). *Pharmacology & therapeutics*. [Basic Science / Preclinical]
Wang Q (2024). [PMID: 38802593](https://pubmed.ncbi.nlm.nih.gov/38802593/). *Annals of hematology*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 4:06 PM UTC
Common questions about acute myeloid leukemia, KIT exon 8 mutation